The ELISPOT Assay: An Easily Transferable Method for Measuring Cellular Responses and Identifying T Cell Epitopes
Identifieur interne : 003374 ( Main/Exploration ); précédent : 003373; suivant : 003375The ELISPOT Assay: An Easily Transferable Method for Measuring Cellular Responses and Identifying T Cell Epitopes
Auteurs : Tumelo Mashishi ; Clive M. GraySource :
- Clinical Chemistry and Laboratory Medicine [ 1434-6621 ] ; 2002.
English descriptors
- Teeft :
- Amino, Amino acids, Assay, Cell immunity, Cell receptor, Cell responses, Clinical trials, Common peptide, Cytokine, Cytokine secretion, Cytotoxic, Different laboratories, Effector, Elispot, Elispot assay, Epitope, Human immunodeficiency virus type, Human leukocyte antigen, Immunodeficiency, Immunol, Immunol lett, Immunol methods, Lymphoblastoid cell lines, Lymphocyte, Mashishi, Matrix, Pbmc, Peptide, Peptide synthesis, Peripheral blood, Recombinant vaccinia virus, Representative example, Vaccine, Vaccinia, Viral.
Abstract
Characterization of human leukocyte antigen (HLA) class I restricted epitopes derived from viral pathogens is imperative for formulating therapeutic interventions, as well as for vaccine design and monitoring. Sensitive, easy and cost-effective assays that measure the frequency of antigen-specific T lymphocytes are crucial for evaluating and improving vaccines and therapies. This paper reviews the ELISPOT technique that allows for quantifying HIV-specific T lymphocytes at the single cell level from peripheral blood by detection of antigen-induced cytokine secretion. The assay can be used successfully to quantify T cell immune responses in humans infected with different pathogens and to assess T cell immunogenicity of vaccines in phase I/II and III clinical trials. This review focuses on the ELISPOT methodology and discusses how it can be standardized and potentially used by multiple international laboratories attached to clinical trial sites.
Url:
DOI: 10.1515/CCLM.2002.159
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000A26
- to stream Istex, to step Curation: 000A26
- to stream Istex, to step Checkpoint: 000D33
- to stream Main, to step Merge: 003410
- to stream Main, to step Curation: 003374
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The ELISPOT Assay: An Easily Transferable Method for Measuring Cellular Responses and Identifying T Cell Epitopes</title><author><name sortKey="Mashishi, Tumelo" sort="Mashishi, Tumelo" uniqKey="Mashishi T" first="Tumelo" last="Mashishi">Tumelo Mashishi</name></author><author><name sortKey="Gray, Clive M" sort="Gray, Clive M" uniqKey="Gray C" first="Clive M." last="Gray">Clive M. Gray</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:B4ABBF9173DB1BDD05C44D7E347C63FC1F50D1AE</idno><date when="2002" year="2002">2002</date><idno type="doi">10.1515/CCLM.2002.159</idno><idno type="url">https://api.istex.fr/ark:/67375/QT4-7R9D2BNG-W/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000A26</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000A26</idno><idno type="wicri:Area/Istex/Curation">000A26</idno><idno type="wicri:Area/Istex/Checkpoint">000D33</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000D33</idno><idno type="wicri:doubleKey">1434-6621:2002:Mashishi T:the:elispot:assay</idno><idno type="wicri:Area/Main/Merge">003410</idno><idno type="wicri:Area/Main/Curation">003374</idno><idno type="wicri:Area/Main/Exploration">003374</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">The ELISPOT Assay: An Easily Transferable Method for Measuring Cellular Responses and Identifying T Cell Epitopes</title><author><name sortKey="Mashishi, Tumelo" sort="Mashishi, Tumelo" uniqKey="Mashishi T" first="Tumelo" last="Mashishi">Tumelo Mashishi</name></author><author><name sortKey="Gray, Clive M" sort="Gray, Clive M" uniqKey="Gray C" first="Clive M." last="Gray">Clive M. Gray</name></author></analytic><monogr></monogr><series><title level="j" type="abbrev">Clinical Chemistry and Laboratory Medicine</title><idno type="ISSN">1434-6621</idno><imprint><publisher>Walter de Gruyter</publisher><date type="published">2002</date><date type="e-published">2005</date><biblScope unit="vol">40</biblScope><biblScope unit="issue">9</biblScope><biblScope unit="page" from="903">903</biblScope><biblScope unit="page" to="910">910</biblScope></imprint><idno type="ISSN">1434-6621</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1434-6621</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Amino</term><term>Amino acids</term><term>Assay</term><term>Cell immunity</term><term>Cell receptor</term><term>Cell responses</term><term>Clinical trials</term><term>Common peptide</term><term>Cytokine</term><term>Cytokine secretion</term><term>Cytotoxic</term><term>Different laboratories</term><term>Effector</term><term>Elispot</term><term>Elispot assay</term><term>Epitope</term><term>Human immunodeficiency virus type</term><term>Human leukocyte antigen</term><term>Immunodeficiency</term><term>Immunol</term><term>Immunol lett</term><term>Immunol methods</term><term>Lymphoblastoid cell lines</term><term>Lymphocyte</term><term>Mashishi</term><term>Matrix</term><term>Pbmc</term><term>Peptide</term><term>Peptide synthesis</term><term>Peripheral blood</term><term>Recombinant vaccinia virus</term><term>Representative example</term><term>Vaccine</term><term>Vaccinia</term><term>Viral</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Characterization of human leukocyte antigen (HLA) class I restricted epitopes derived from viral pathogens is imperative for formulating therapeutic interventions, as well as for vaccine design and monitoring. Sensitive, easy and cost-effective assays that measure the frequency of antigen-specific T lymphocytes are crucial for evaluating and improving vaccines and therapies. This paper reviews the ELISPOT technique that allows for quantifying HIV-specific T lymphocytes at the single cell level from peripheral blood by detection of antigen-induced cytokine secretion. The assay can be used successfully to quantify T cell immune responses in humans infected with different pathogens and to assess T cell immunogenicity of vaccines in phase I/II and III clinical trials. This review focuses on the ELISPOT methodology and discusses how it can be standardized and potentially used by multiple international laboratories attached to clinical trial sites.</div></front></TEI><affiliations><list></list><tree><noCountry><name sortKey="Gray, Clive M" sort="Gray, Clive M" uniqKey="Gray C" first="Clive M." last="Gray">Clive M. Gray</name><name sortKey="Mashishi, Tumelo" sort="Mashishi, Tumelo" uniqKey="Mashishi T" first="Tumelo" last="Mashishi">Tumelo Mashishi</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003374 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003374 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:B4ABBF9173DB1BDD05C44D7E347C63FC1F50D1AE
|texte= The ELISPOT Assay: An Easily Transferable Method for Measuring Cellular Responses and Identifying T Cell Epitopes
}}
| This area was generated with Dilib version V0.6.33. |  |